Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $13.891; its P/E ratio is 28.38; Vertex Pharmaceuticals is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $4.07. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.52B	$ 2.48B	$ 2.49B	$ 2.37B	$ 2.30B
Gross Profit	$ 2.15B	$ 2.16B	$ 2.18B	$ 2.11B	$ 2.02B
EBIT	$ 1.17B	$ 1.19B	$ 1.17B	$ 902.90M	$ 1.09B
EBITDA	$ 1.23B	-	$ 1.21B	$ 941.70M	-
Net Income Common Stockholders	$ 968.80M	$ 1.04B	$ 915.70M	$ 699.80M	$ 818.90M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 11.22B	$ 11.93B	$ 11.24B	$ 10.41B	$ 10.78B
Total Assets	$ 22.73B	$ 21.73B	$ 20.35B	$ 18.97B	$ 18.16B
Total Debt	$ 724.70M	$ 744.70M	$ 767.60M	$ 789.20M	$ 810.30M
Net Debt	$ -10.49B	$ -11.18B	$ -10.47B	$ -9.62B	$ -9.97B
Total Liabilities	$ 5.15B	$ 5.21B	$ 4.88B	$ 4.54B	$ 18.15B
Stockholders Equity	$ 17.58B	$ 16.51B	$ 15.47B	$ 14.43B	$ 13.91B
Cash Flow	-
Free Cash Flow	$ 118.50M	-	$ 1.08B	$ 859.70M	$ 1.04B
Operating Cash Flow	$ 234.60M	$ 1.27B	$ 1.14B	$ 901.80M	$ 1.08B
Investing Cash Flow	$ -886.50M	$ -115.20M	$ -304.50M	$ -1.84B	$ 177.40M
Financing Cash Flow	$ -119.80M	$ -165.00M	$ 17.30M	$ -294.70M	$ 40.20M

Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Income Statement >

Vertex Pharmaceuticals Debt to Assets

Balance Sheet >

Vertex Pharmaceuticals Cash Flow

Cash Flow >

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing